Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2011-09-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2011.151464PMID 21908880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test. Diabetes Care 2001;24:539–548

  2014cited by this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  2010cited by this paper
• Insulin resistance in early untreated rheumatoid arthritis patients.

  2010cited by this paper
• Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.

  2010cited by this paper
• Glucose intolerance in patients with chronic inflammatory diseases is normalized by glucocorticoids.

  2009cited by this paper
• Novel insights into glucocorticoid‐mediated diabetogenic effects: towards expansion of therapeutic options?

  2009cited by this paper
• Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.

  2009influential reference
• Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.

  2008cited by this paper
• Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

  2008cited by this paper
• Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older.

  2007cited by this paper
• EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

  2007cited by this paper
• Effect of liver fat on insulin clearance.

  2007cited by this paper
• Insulin resistance and impaired beta cell function in rheumatoid arthritis.

  2006cited by this paper
• Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

  2006cited by this paper
• Cardiovascular death in rheumatoid arthritis: a population-based study.

  2005cited by this paper
• Use and abuse of HOMA modeling.

  2004cited by this paper
• Glucocorticoids and insulin sensitivity in rheumatoid arthritis.

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Methods for clinical assessment of insulin sensitivity and β-cell function

  2003cited by this paper
• Methods for clinical assessment of insulin sensitivity and beta-cell function.

  2003cited by this paper
• The acute phase response does not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis.

  2002cited by this paper
• Keeping up appearances

  2002cited by this paper
• Effects of disease modifying agents and dietary intervention on insulin resistance and dyslipidemia in inflammatory arthritis: a pilot study

  2002cited by this paper
• A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test

  2001cited by this paper
• Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program

  1998cited by this paper
• Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.

  1997cited by this paper
• Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

  1995cited by this paper
• Glucocorticoids and the risk for initiation of hypoglycemic therapy.

  1994cited by this paper
• Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.

  1993cited by this paper
• Effects of glucocorticoids on carbohydrate metabolism.

  1988cited by this paper
• Impaired glucose handling in active rheumatoid arthritis: effects of corticosteroids and antirheumatic treatment.

  1987cited by this paper
• Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range

  1974cited by this paper

• Multi-target drug discovery for rheumatoid arthritis: a comprehensive computational approach using bioactive compounds

  2025cites this paper
• Risiko der Entwicklung einer Hyperglykämie unter einer Kortisontherapie im Krankenhaus

  2025cites this paper
• Modern Pulse Corticosteroid Therapy in Patients with Multiple Sclerosis: Adverse Events and Clinical and Pharmacological Measures to Eliminate Them

  2025cites this paper
• Glucocorticoid‐induced hyperglycaemia in hospitalised adults: A matched cohort study (2013–2023)

  2025cites this paper
• [Type 2 diabetes mellitus in rheumatoid arthritis and systemic lupus erythematosus: A review].

  2025cites this paper
• The presumable combined effects of hydroxychloroquine and its metabolites on the blood lipids and glucose in the treatment of rheumatoid arthritis

  2025cites this paper
• The association between abnormal glucose metabolism and rheumatoid arthritis.

  2025cites this paper
• Excessive apoptosis, glycolysis, and abnormal levels of gluconeogenase in rheumatoid arthritis involves in the dysregulation of glucose metabolism: an animal model study

  2025cites this paper
• SJÖGREN SENDROMUNDA GÜNCEL İLAÇ TEDAVİSİ

  2024cites this paper
• PULSE THERAPY WITH CORTICOSTEROIDS IN PATIENTS WITH MULTIPLE SCLEROSIS: ADVERSE EVENTS AND WAYS TO OVERCOME THEM

  2024cites this paper
• Effect of heat-reinforcing needling on hypoxia-inducible factor 1α and glycolysis activity in rabbits with cold syndrome of rheumatoid arthritis.

  2024cites this paper
• Evaluation of the effect of long-term use of glucocorticoids on the risk of developing diabetes mellitus in patients with gout

  2023cites this paper
• Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

  2023cites this paper
• NR3C1/Glucocorticoid receptor activation promotes pancreatic β-cell autophagy overload in response to glucolipotoxicity

  2023cites this paper
• Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association

  2022cites this paper
• Insulin resistance and adverse lipid profile in untreated very early rheumatoid arthritis patients: A single-center, cross-sectional study in China

  2022cites this paper
• Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions

  2022cites this paper
• Prevalence, Clinical Manifestations, and Treatment Pattern of Patients with Rheumatoid Arthritis Attending the Rheumatology Clinic at Tikur Anbessa Specialized Hospital, Ethiopia: A Cross-Sectional Study

  2022cites this paper
• Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitus

  2022cites this paper
• Prevalence, Clinical Manifestations, and Treatment Pattern of Patients with Rheumatoid Arthritis Attending the Rheumatology Clinic at Tikur Anbessa Specialized Hospital, Ethiopia: A Cross-Sectional Study

  2022cites this paper
• High prevalence of undiagnosed impaired glucose tolerance in patients with rheumatoid arthritis

  2022cites this paper
• Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis

  2022cites this paper
• The Long-term (five years) Effects of Prednisone Therapy in Children with Frequently Relapsing Nephrotic Syndrome: A Controlled Study of Anthropometric Parameters and Metabolic Abnormalities

  2022cites this paper
• Insulin Signaling in Arthritis

  2021cites this paper
• The mechanism of leptin and IGF-1 in the diabetic rheumatoid arthritis Iraqi patients

  2021cites this paper
• An observational assessment of the most common rheumatological manifestations in patients with type 2 diabetes

  2021cites this paper
• Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis

  2021cites this paper
• Sicherheitsaspekte der Therapie mit Glukokortikoiden bei rheumatoider Arthritis

  2021cites this paper
• Association of Rheumatoid Arthritis with Diabetic Comorbidity: Correlating Accelerated Insulin Resistance to Inflammatory Responses in Patients

  2021cites this paper
• Important Management Considerations In Patients With Pituitary Disorders During The Time Of The Covid-19 Pandemic

  2020cites this paper
• High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study.

  2020cites this paper
• The effect of glucocorticoid therapy on mortality in patients with rheumatoid arthritis and concomitant type II diabetes: a retrospective cohort study

  2020cites this paper
• Undiagnosed Dysglycemia in Patients with Rheumatoid Arthritis and Its Associated Factors

  2020influential citation
• Flattened circadian glucocorticoid oscillations cause obesity due to increased lipid turnover and lipid uptake

  2020cites this paper
• Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

  2019cites this paper
• Risk factors and management of corticosteroid‐induced hyperglycaemia in paediatric acute lymphoblastic leukaemia

  2019cites this paper
• Dysfonction endothéliale au niveau de différents territoires vasculaires en cas de polyarthrite rhumatoïde : physiopathologie et perspectives thérapeutiques

  2019cites this paper
• Management of Cardiovascular Disease Risk in Rheumatoid Arthritis

  2019cites this paper
• Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration.

  2019cites this paper
• New concepts to reduce glucocorticoid toxicity.

  2019cites this paper
• Diabetogenesis in Rheumatoid Arthritis: Do Inflammation and Glucocorticoid-induced Incretin Overproduction Cause β-Cell Overcompensation and Consequent Premature Decompensation?

  2019cites this paper
• Corticosteroid Adverse Effects

  2019cites this paper
• What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?

  2019cites this paper
• Atherosclerotic cardiovascular disease in rheumatoid arthritis : aspects of pathogenesis and risk

  2019cites this paper
• GLUCOCORTICOSTEROIDS AND DEVELOPMENT OF DIABETES MELLITUS (LITERATURE REVIEW)

  2019cites this paper
• Insulin resistance in rheumatoid arthritis: relationship to lipid metabolism disorders and metabolic syndrome

  2019cites this paper
• Glucocorticoids for rheumatoid arthritis in the era of targeted therapies.

  2019cites this paper
• Impact of Drugs on Diabetes Risk and Glycemic Control

  2019cites this paper
• Nouveaux concepts destinés à réduire la toxicité des glucocorticoïdes

  2019cites this paper
• Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta-analysis

  2018cites this paper
• Gestational glucocorticoid exposure disrupts glucose homeostasis that is accompanied by increased endoglin and DPP-4 activity instead of GSK-3 in rats.

  2018cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia.

  2018cites this paper
• Glucocorticoids Are Always Under Suspicion — Is the Perception of Their Risks Unbiased?

  2018cites this paper
• MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia

  2018cites this paper
• Effect of high-dose dexamethasone on patients without diabetes during elective neurosurgery: a prospective study

  2018cites this paper
• Long-term treatment with low dose glucocorticoids in Rheumatoid Arthritis: New tricks of an old drug

  2018cites this paper
• Steroid-induced Diabetes Complicating Treatment of Epidermolysis Bullosa Acquisita: A Preventable Treatment Complication Stresses the Importance of Primary Care Follow-up

  2018cites this paper
• Metformin prevents metabolic side effects during systemic glucocorticoid treatment.

  2017cites this paper
• Polyarthrite rhumatoïde, insulino-résistance et diabète ☆

  2017cites this paper
• Comorbidity in Rheumatic Diseases

  2017cites this paper
• Separating the Anti-Inflammatory and Diabetogenic Effects of Glucocorticoids Through LXR&bgr; Antagonism

  2017influential citation
• Abnormal Glucose Metabolism in Rheumatoid Arthritis

  2017cites this paper
• Rheumatoid arthritis, insulin resistance, and diabetes.

  2017cites this paper
• A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy

  2017cites this paper
• HIGH-DOSE GLUCOCORTICOID TREATMENT DOES NOT INDUCE SEVERE HYPERGLYCEMIA IN YOUNG PATIENTS WITH AUTOIMMUNE DISEASES BY CGMS.

  2017cites this paper
• Glucocorticoids and Rheumatoid Arthritis.

  2016cites this paper
• Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

  2016cites this paper
• Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence

  2016cites this paper
• Relationship Between Glucocorticoids and Insulin Resistance in Healthy Individuals

  2016cites this paper
• Risk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid Arthritis

  2016cites this paper
• Effect of acute and chronic glucocorticoid therapy on insulin sensitivity and postprandial vascular function

  2016cites this paper
• Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures

  2016cites this paper
• Association between diet and treatment results in patients with rheumatoid arthritis and systemic lupus erythematosus

  2016cites this paper
• Glycemic Stability Through Islet‐After‐Kidney Transplantation Using an Alemtuzumab‐Based Induction Regimen and Long‐Term Triple‐Maintenance Immunosuppression

  2016cites this paper
• Metabolic Syndrome in Rheumatoid Arthritis

  2015cites this paper
• Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature

  2015cites this paper
• Molecular Regulation of Gluconeogenesis by the Nuclear Receptors GR and LXRβ

  2015cites this paper
• Glucocorticoids in the treatment of rheumatoid arthritis.

  2015cites this paper
• Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritis

  2015cites this paper
• Insulin Resistance in Rheumatoid Arthritis: Disease‐Related Indicators and Associations With the Presence and Progression of Subclinical Atherosclerosis

  2015cites this paper
• Glucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes.

  2015cites this paper
• Glucocorticoid safety for treating rheumatoid arthritis

  2015cites this paper
• Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritis.

  2015cites this paper
• Der ältere multimorbide Rheuma-Patient – Teil 2

  2014cites this paper
• The current relevance and use of prednisone in rheumatoid arthritis

  2014influential citation
• Does dipeptidyl peptidase-4 inhibition prevent the diabetogenic effects of glucocorticoids in men with the metabolic syndrome? A randomized controlled trial.

  2014cites this paper
• Adipose Depots, Not Disease-related Factors, Account for Skeletal Muscle Insulin Sensitivity in Established and Treated Rheumatoid Arthritis

  2014cites this paper
• Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomised trial

  2014cites this paper
• Methotrexate Promotes Glucose Uptake and Lipid Oxidation in Skeletal Muscle via AMPK Activation

  2014cites this paper
• Effects of Selective and Non-Selective Glucocorticoid Receptor II Antagonists on Rapid-Onset Diabetes in Young Rats

  2014cites this paper
• The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects

  2014cites this paper
• Identifying factors hampering physical activity in longstanding rheumatoid arthritis: what is the role of glucocorticoid therapy?

  2014cites this paper
• Safety of Glucocorticoids in Rheumatoid Arthritis: Evidence from Recent Clinical Trials

  2014cites this paper
• Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years

  2014cites this paper
• Is Visceral Fat the Missing Link in the Relationship Between Inflammation and Insulin Resistance in RA?

  2014cites this paper
• Steroid diabetes: from mechanism to treatment?

  2014cites this paper
• PROPHYLAXIS AND THERAPY OF IMPAIRED GLUCOSE TOLERANCE IN LONG-TERM THERAPY OF THE PATIENTS WITH SEVERE DERMATOSES WITH GLUCOCORTICOSTEROID HORMONES

  2014cites this paper
• Study of insulin resistance in patients with systemic lupus erythematosus and rheumatoid arthritis

  2014cites this paper
• Insulin Resistance in RA ? Is Visceral Fat the Missing Link in the Relationship Between Inflammation and

  2014cites this paper
• Carbohydrate metabolism disorders in patients with rheumatoid arthritis and ankylosing spondylitis – impact of treatment

  2014cites this paper